We’re in the last stretch of our fall fundraising drive, and we’re still short of our goal. In an era of media consolidation into the hands of billionaires and corporate owners, we remain independent. Can you chip in today?
by
Dean Baker
The NYT had a very good piece about how the shift of 6 million Medicaid beneficiaries into the Medicare drug benefit program may increase drug company profits in 2006 by $2 billion. According to the article, under the new program the drug companies get to sell the same drugs at higher prices. It doesn’t get much better than this!
–Dean Baker
Dean Baker is senior economist at the Center for Economic and Policy Research in Washington, D.C. He is the author of several books, including Rigged: How Globalization and the Rules of the Modern Economy Were Structured to Make the Rich Richer. Read more about Dean. More by Dean Baker
The Prospect runs on readers
No paywall, no corporate owners. Everything you read here is paid for by people like you. Chip in to keep it that way.
Cut through the noise of daily news with in-depth, progressive analysis.
Unsubscribe anytime. Submitting your email signs you up for our daily and weekly newsletters.
Cut through the noise of daily news with in-depth, progressive analysis.
Unsubscribe anytime. Submitting your email signs you up for our daily and weekly newsletters.
We'll create a new account for .
